¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå : »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2025-2032³â)
CBD Nutraceuticals Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research»ç´Â ÃÖ±Ù CBD ´ºÆ®¶ó½´Æ¼ÄÃ(¿µ¾çÁ¦) ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» ¹ßÇ¥Çß½À´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå ±Ô¸ð(2025³â) : 104¾ï ´Þ·¯
½ÃÀå ±Ô¸ð ¿¹Ãø(±Ý¾× ±âÁØ, 2032³â) : 234¾ï ´Þ·¯
¼¼°è ½ÃÀåÀÇ ¼ºÀå·ü(CAGR, 2025-2032³â) : 12.3%
CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå - ºÐ¼® ¹üÀ§
CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀåÀº ±¸¹Ì, ÆÃÅ©, ĸ½¶, ±¹¼Ò Á¦Á¦ µî ijªºñµð¿Ã(CBD)¿¡¼ ÆÄ»ýµÈ ´Ù¾çÇÑ °Ç° ¹× À£ºù Á¦Ç°À» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°Àº ƯÈ÷ ÅëÁõ ¿ÏÈ, ¼ö¸é Áö¿ø, ÇǺΠ°Ç° ¹× À£ºù¿¡ ´ëÇÑ Ä¡·á È¿°ú·Î ³Î¸® ¼ÒºñµÇ°í ÀÖ½À´Ï´Ù. ´ë¸¶ÃÊ ±â¹Ý Á¦Ç°ÀÇ Àü ¼¼°èÀû ¼ö¿ëÀÌ Áõ°¡Çϰí õ¿¬ °Ç° º¸ÃæÁ¦·ÎÀÇ ÀüȯÀÌ ÁøÇàµÊ¿¡ µû¶ó ½ÃÀåÀº ±Þ¼ÓÇÑ È®ÀåÀ» ¸ñ°ÝÇϰí ÀÖ½À´Ï´Ù. ÇÕ¹ýÈÀÇ È®´ë¿Í ½Ä¹° ±â¹Ý À£´Ï½º ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼±È£µµÀÇ º¯È´Â ÀÌ·¯ÇÑ ¼ºÀåÀ» °è¼ÓÇØ¼ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ :
¿©·¯ °¡Áö ÁÖ¿ä ¿äÀÎÀÌ Àü ¼¼°è CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Ç׿°, ÁøÅë, ºÒ¾È ¿ÏÈ µî CBDÀÇ Ä¡·á È¿´É¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ¼ÒºñÀÚ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¹Ð·¹´Ï¾ó ¼¼´ë¿Í Z ¼¼´ë¸¦ Áß½ÉÀ¸·Î °Ç°°ú À£ºù¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö¸é¼ CBD ±â¹Ý ±â´É¼º Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿©·¯ ±¹°¡¿¡¼ ´ë¸¶ÃÊ¿Í CBD°¡ Á¡Â÷ ÇÕ¹ýÈµÇ¸é¼ ±ÔÁ¦ À庮ÀÌ ¿ÏȵǾî Á¦Ç° Çõ½Å°ú À¯Åë È®´ë°¡ °¡´ÉÇØÁ³½À´Ï´Ù. ÀüÀÚ »ó°Å·¡ Ç÷§ÆûÀÇ È®ÀåÀº Á¦Ç° Á¢±Ù¼ºÀ» Çâ»ó½ÃÄÑ ½ÃÀå ħÅõ¸¦ ÃËÁøÇß½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :
°·ÂÇÑ ¼ºÀå¼¼¿¡µµ ºÒ±¸Çϰí CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀåÀº ÁÖ¸ñÇÒ ¸¸ÇÑ °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ±¹°¡ ¹× Áö¿ª¸¶´Ù ±ÔÁ¦ ºÒÀÏÄ¡°¡ Á¸ÀçÇÏ¿© CBD Á¦Ç°ÀÇ ¿øÈ°ÇÑ °Å·¡ ¹× ¸¶ÄÉÆÃ¿¡ Àå¾Ö°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀϺΠ°Ç° °ü·Ã ÁÖÀå¿¡ ´ëÇÑ Ç¥ÁØÈµÈ Åõ¿©·® ¹× ÀÓ»ó °ËÁõÀÇ ºÎÁ·Àº ¼ÒºñÀÚ¿Í ÀÇ·á Àü¹®°¡µéÀÇ ¿ì·Á¸¦ ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ´ë¸¶ÃÊ °ü·Ã Á¦Ç°¿¡ ´ëÇÑ À߸øµÈ Á¤º¸¿Í ¿À¸íµµ ¼ÒºñÀÚÀÇ ÁÖÀúÇÔÀ» ¾ß±âÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ôÀº Á¦Ç° °¡°Ý°ú ´ëü °Ç° Á¦Ç°¿¡ ´ëÇÑ º¸Çè Àû¿ëÀÇ Á¦ÇÑÀº ƯÈ÷ °¡°Ý¿¡ ¹Î°¨ÇÑ ½ÃÀå¿¡¼ Á¦Ç° äÅÃÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù.
½ÃÀå ±âȸ :
ÀÌ ½ÃÀåÀº CBDÀÇ ÀÇÇÐÀû È¿´É¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿¬±¸¿Í °³ÀÎ ¸ÂÃãÇü ¿µ¾ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î »ó´çÇÑ ¼ºÀå ±âȸ¸¦ º¸À̰í ÀÖ½À´Ï´Ù. Á¦Ç° Á¦Çü Çõ½Å(¿¹: »ýü ÀÌ¿ë·üÀ» ³ôÀÌ´Â ³ª³ë¿¡¸ÖÀü)Àº »õ·Î¿î ¼öÀÍ¿øÀ» âÃâÇϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚÀÇ ºñ°Ç, À¯±â³ó, Ŭ¸° ¶óº§ Á¦Ç° ¼±È£µµ°¡ Áõ°¡ÇÔ¿¡ µû¶ó CBD ÇÔÀ¯ ¿µ¾çÁ¦ ½ÃÀåÀÌ ¼ºÀå ±â¹ÝÀ» ¸¶·ÃÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ½ÅÈï ½ÃÀå¿¡¼´Â ÀνÄÀÌ È®»êµÇ°í ±ÔÁ¦°¡ Á¡Â÷ °³¼±µÇ¸é¼ ¹Ì°³Ã´ ÀáÀç·ÂÀÌ Á¸ÀçÇÕ´Ï´Ù. CBD ºê·£µå¿Í ÁÖ¿ä ½Äǰ, Á¦¾à, À£´Ï½º ±â¾÷ °£ÀÇ Çù¾÷Àº ½ÃÀå È®´ë¿Í ½Å·Ú ±¸ÃàÀ» °¡¼ÓÈÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´äº¯À» ¾òÀ» ¼ö ÀÖ´Â ÁÖ¿ä Áú¹®
¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº? CBD ´ºÆ®¶ó½´Æ¼Äà ¼ö¿ä°¡ °¡Àå ³ôÀº Áö¿ª°ú Á¦Ç° ºÐ¾ß´Â? Á¦Á¦³ª Àü´Þ ¹æ¹ýÀÇ ¹ßÀüÀº ½ÃÀå ¿ªÇп¡ ¾î¶² ¿µÇâÀ» ÁÖ°í Àִ°¡? CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ¾î´À °ÍÀ̸ç, ±× Àü·«Àû Á¢±ÙÀº? ¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀåÀÇ Ãֽе¿Çâ°ú ¿¹ÃøÀº?
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¾ïÁ¦¿äÀÎ
±âȸ
ÁÖ¿ä µ¿Çâ
°Å½Ã°æÁ¦ ¿äÀÎ
¼¼°èÀÇ ¼½Åͺ° Àü¸Á
¼¼°è GDP ¼ºÀå Àü¸Á
COVID-19ÀÇ ¿µÇ⠺м®
¿¹Ãø ¿äÀÎ : °ü·Ã¼º°ú ¿µÇâ
Á¦3Àå ºÎ°¡°¡Ä¡ ºÐ¼®
Á¦Ç° äÅà ºÐ¼®
±ÔÁ¦ »óȲ
¹ë·ùüÀÎ ºÐ¼®
PESTLE ºÐ¼®
Porter's Five Forces ºÐ¼®
Á¦4Àå ¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ±Ô¸ð¿Í Àü³â´ëºñ ¼ºÀå·ü(±Ý¾× ±âÁØ)
Àý´ë ¼öÀÍ ±âȸ
½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø(±Ý¾× ±âÁØ)
°ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®(±Ý¾× ±âÁØ, 2019-2024³â)
ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø(±Ý¾× ±âÁØ, 2025-2032³â)
¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á : Á¦Ç°º°
¼Ò°³ ¹× ÁÖ¿ä ºÐ¼® °á°ú
°ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Á¦Ç°º°(±Ý¾× ±âÁØ, 2019-2024³â)
ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°(±Ý¾× ±âÁØ, 2025-2032³â)
CBD ±¸¹Ì
CBD ÆÃÅ©
ĸ½¶ ¹× ¼ÒÇÁÆ®Á©
¿¬°í ¹× ¹ã
±âŸ
½ÃÀå ¸Å·Â ºÐ¼® : Á¦Ç°º°
¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á : Çü»óº°
¼Ò°³ ¹× ÁÖ¿ä ºÐ¼® °á°ú
°ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Çü»óº°(±Ý¾× ±âÁØ, 2019-2024³â)
ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : Çü»óº°(±Ý¾× ±âÁØ, 2025-2032³â)
½ÃÀå ¸Å·Â ºÐ¼® : Çü»óº°
¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á : ¿ëµµº°
¼Ò°³ ¹× ÁÖ¿ä ºÐ¼® °á°ú
°ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ¿ëµµº°(±Ý¾× ±âÁØ, 2019-2024³â)
ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°(±Ý¾× ±âÁØ, 2025-2032³â)
ÅëÁõ °ü¸®
¼ö¸é Áö¿ø
ÇǺΠ°Ç°°ú ¹Ì¿ë
Æ®·¹ÀÌ´×¿ë º¸ÃæÁ¦
±âŸ
½ÃÀå ¸Å·Â ºÐ¼® : ¿ëµµº°
¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á : À¯Åë ä³Îº°
¼Ò°³ ¹× ÁÖ¿ä ºÐ¼® °á°ú
°ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : À¯Åë ä³Îº°(±Ý¾× ±âÁØ, 2019-2024³â)
ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : À¯Åë ä³Îº°(±Ý¾× ±âÁØ, 2025-2032³â)
º´¿ø ¾à±¹
¼Ò¸Å ¾à±¹
¿Â¶óÀÎ ¾à±¹
½ÃÀå ¸Å·Â ºÐ¼® : À¯Åë ä³Îº°
Á¦5Àå ¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á : Áö¿ªº°
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
°ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Áö¿ªº°(±Ý¾× ±âÁØ, 2019-2024³â)
ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°(±Ý¾× ±âÁØ, 2025-2032³â)
ºÏ¹Ì
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ªº°
Á¦6Àå ºÏ¹ÌÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
Á¦7Àå À¯·´ÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
Á¦12Àå °æÀï ±¸µµ
½ÃÀå Á¡À¯À² ºÐ¼®(2025³â)
½ÃÀå ±¸Á¶
°æÀï °µµ ¸Ê : ½ÃÀ庰
°æÀï ´ë½Ãº¸µå
±â¾÷ ÇÁ·ÎÆÄÀÏ(»ó¼¼ : °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
GVB Biopharma
Brains
NOW
Dr. CBD Company Limited
dsm-firmenich
Charlotte's Web, Inc.
Elixinol
Medical Marijuana, Inc.
CV Sciences, Inc.
Irwin Naturals
Diamond CBD
Eden Partners LLC
Medterra CBD
Green Roads
Isodiol International Inc
Garden of Life
Bluebird Botanicals(Gaia Botanicals, LLC)
Endoca
One Farm
Treadwell Farms
CBD Worx
USA Medical
NuLeaf Naturals, LLC
EarlyBird CBD
Á¦13Àå ºÎ·Ï
ºÐ¼® ¹æ¹ý
ºÐ¼®ÀÇ ÀüÁ¦
µÎÀÚ¾î ¹× ¾à¾î
HBR
Persistence Market Research has recently released a comprehensive report on the global CBD Nutraceuticals Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.
Key Insights:
CBD Nutraceuticals Market Size (2025E): US$ 10.4 Bn
Projected Market Value (2032F): US$ 23.4 Bn
Global Market Growth Rate (CAGR 2025 to 2032): 12.3%
CBD Nutraceuticals Market - Report Scope:
The CBD nutraceuticals market includes a broad array of dietary and wellness products derived from cannabidiol (CBD), such as gummies, tinctures, capsules, and topicals. These products are widely consumed for their therapeutic benefits, particularly in pain relief, sleep support, skin health, and wellness. With the growing global acceptance of cannabis-based products and a shift towards natural health supplements, the market is witnessing rapid expansion. Increased legalization and changing consumer preferences toward plant-based wellness solutions continue to fuel this growth.
Market Growth Drivers:
Several key factors are fueling the growth of the global CBD nutraceuticals market. Increasing awareness about the therapeutic benefits of CBD, including its anti-inflammatory, analgesic, and anxiolytic properties, is significantly boosting consumer demand. Rising health and wellness consciousness, especially among millennials and Gen Z, has created a fertile ground for CBD-based functional products. In addition, the gradual legalization of cannabis and CBD in several countries has eased regulatory barriers, enabling product innovation and wider distribution. The expansion of e-commerce platforms has also enhanced product accessibility, driving market penetration.
Market Restraints:
Despite its strong growth trajectory, the CBD nutraceuticals market faces notable challenges. Regulatory inconsistencies across different countries and regions hinder the seamless trade and marketing of CBD products. Moreover, the lack of standardized dosing and limited clinical validation for some health claims raises concerns among consumers and medical professionals. Misinformation and stigma surrounding cannabis-related products also contribute to consumer hesitancy. Additionally, high product costs and limited insurance coverage for alternative wellness products may restrict adoption, particularly in price-sensitive markets.
Market Opportunities:
The market presents substantial growth opportunities fueled by ongoing research into the medical benefits of CBD and increasing demand for personalized nutrition. Innovations in product formulations-such as nanoemulsions for better bioavailability-are creating new revenue streams. The rise in consumer preference for vegan, organic, and clean-label products provides a strong platform for CBD-infused nutraceuticals. Emerging markets in Asia-Pacific and Latin America, where awareness is growing and regulations are gradually evolving, also offer untapped potential. Collaborations between CBD brands and mainstream food, pharma, and wellness companies could further expand market reach and trust.
Key Questions Answered in the Report:
What are the primary factors driving the global CBD nutraceuticals market's growth?
Which regions and product segments are witnessing the highest demand for CBD nutraceuticals?
How are advancements in formulation and delivery methods influencing market dynamics?
Who are the key players in the CBD nutraceuticals market, and what are their strategic approaches?
What are the latest trends and future projections for the global CBD nutraceuticals market?
Competitive Intelligence and Business Strategy:
Leading companies in the global CBD nutraceuticals market such as GVB Biopharma, Charlotte's Web, Inc., Elixinol, and CV Sciences, Inc. are heavily investing in product innovation, clinical validation, and brand-building efforts. These players are focusing on broadening their product portfolios with targeted solutions for pain relief, sleep, and beauty. Strategic partnerships with retailers, pharmacies, and digital platforms are helping companies expand distribution. Additionally, emphasis on transparency, third-party lab testing, and sustainable sourcing is building consumer trust and fostering long-term brand loyalty.
Companies Covered in This Report:
GVB Biopharma
Brains
NOW
Dr. CBD Company Limited
dsm-firmenich
Charlotte's Web, Inc.
Elixinol
Medical Marijuana, Inc.
CV Sciences, Inc.
Irwin Naturals
Diamond CBD
Foria Wellness (Eden Partners LLC)
Medterra CBD
Market Segmentation:
By Product:
CBD Gummies
CBD Tinctures
Capsules and Softgels
Salves and Balms
Others
By Form:
By Application:
Pain Management
Sleep Support
Skin Health and Beauty
Workout Supplements
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
Europe
East Asia
South Asia and Oceania
Middle East and Africa
Latin America
Table of Contents
1. Executive Summary
1.1. Global CBD Nutraceuticals Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. PESTLE Analysis
3.5. Porter's Five Force Analysis
4. Global CBD Nutraceuticals Market Outlook
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
4.3. Global CBD Nutraceuticals Market Outlook: Product
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2024
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
4.3.3.1. CBD Gummies
4.3.3.2. CBD Tinctures
4.3.3.3. Capsules & Softgels
4.3.3.4. Salves & Balms
4.3.3.5. Others
4.3.4. Market Attractiveness Analysis: Product
4.4. Global CBD Nutraceuticals Market Outlook: Form
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn), By Form, 2019-2024
4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
4.4.3.1. Ingestible
4.4.3.2. Topical
4.4.4. Market Attractiveness Analysis: Form
4.5. Global CBD Nutraceuticals Market Outlook: Application
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn), By Application, 2019-2024
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
4.5.3.1. Pain Management
4.5.3.2. Sleep Support
4.5.3.3. Skin Health & Beauty
4.5.3.4. Workout Supplements
4.5.3.5. Others
4.5.4. Market Attractiveness Analysis: Application
4.6. Global CBD Nutraceuticals Market Outlook: Distribution Channel
4.6.1. Introduction / Key Findings
4.6.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
4.6.3.1. Hospital Pharmacies
4.6.3.2. Retail Pharmacies
4.6.3.3. Online Pharmacies
4.6.4. Market Attractiveness Analysis: Distribution Channel
5. Global CBD Nutraceuticals Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America CBD Nutraceuticals Market Outlook
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
6.2.1. By Country
6.2.2. By Product
6.2.3. By Form
6.2.4. By Application
6.2.5. By Distribution Channel
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
6.4.1. CBD Gummies
6.4.2. CBD Tinctures
6.4.3. Capsules & Softgels
6.4.4. Salves & Balms
6.4.5. Others
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
6.5.1. Ingestible
6.5.2. Topical
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
6.6.1. Pain Management
6.6.2. Sleep Support
6.6.3. Skin Health & Beauty
6.6.4. Workout Supplements
6.6.5. Others
6.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
6.7.1. Hospital Pharmacies
6.7.2. Retail Pharmacies
6.7.3. Online Pharmacies
6.8. Market Attractiveness Analysis
7. Europe CBD Nutraceuticals Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Product
7.2.3. By Form
7.2.4. By Application
7.2.5. By Distribution Channel
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Turkey
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
7.4.1. CBD Gummies
7.4.2. CBD Tinctures
7.4.3. Capsules & Softgels
7.4.4. Salves & Balms
7.4.5. Others
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
7.5.1. Ingestible
7.5.2. Topical
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
7.6.1. Pain Management
7.6.2. Sleep Support
7.6.3. Skin Health & Beauty
7.6.4. Workout Supplements
7.6.5. Others
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
7.7.1. Hospital Pharmacies
7.7.2. Retail Pharmacies
7.7.3. Online Pharmacies
7.8. Market Attractiveness Analysis
8. East Asia CBD Nutraceuticals Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Product
8.2.3. By Form
8.2.4. By Application
8.2.5. By Distribution Channel
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
8.4.1. CBD Gummies
8.4.2. CBD Tinctures
8.4.3. Capsules & Softgels
8.4.4. Salves & Balms
8.4.5. Others
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
8.5.1. Ingestible
8.5.2. Topical
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
8.6.1. Pain Management
8.6.2. Sleep Support
8.6.3. Skin Health & Beauty
8.6.4. Workout Supplements
8.6.5. Others
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
8.7.1. Hospital Pharmacies
8.7.2. Retail Pharmacies
8.7.3. Online Pharmacies
8.8. Market Attractiveness Analysis
9. South Asia & Oceania CBD Nutraceuticals Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Product
9.2.3. By Form
9.2.4. By Application
9.2.5. By Distribution Channel
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
9.4.1. CBD Gummies
9.4.2. CBD Tinctures
9.4.3. Capsules & Softgels
9.4.4. Salves & Balms
9.4.5. Others
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
9.5.1. Ingestible
9.5.2. Topical
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
9.6.1. Pain Management
9.6.2. Sleep Support
9.6.3. Skin Health & Beauty
9.6.4. Workout Supplements
9.6.5. Others
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
9.7.1. Hospital Pharmacies
9.7.2. Retail Pharmacies
9.7.3. Online Pharmacies
9.8. Market Attractiveness Analysis
10. Latin America CBD Nutraceuticals Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Product
10.2.3. By Form
10.2.4. By Application
10.2.5. By Distribution Channel
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
10.4.1. CBD Gummies
10.4.2. CBD Tinctures
10.4.3. Capsules & Softgels
10.4.4. Salves & Balms
10.4.5. Others
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
10.5.1. Ingestible
10.5.2. Topical
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
10.6.1. Pain Management
10.6.2. Sleep Support
10.6.3. Skin Health & Beauty
10.6.4. Workout Supplements
10.6.5. Others
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
10.7.1. Hospital Pharmacies
10.7.2. Retail Pharmacies
10.7.3. Online Pharmacies
10.8. Market Attractiveness Analysis
11. Middle East & Africa CBD Nutraceuticals Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Product
11.2.3. By Form
11.2.4. By Application
11.2.5. By Distribution Channel
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
11.4.1. CBD Gummies
11.4.2. CBD Tinctures
11.4.3. Capsules & Softgels
11.4.4. Salves & Balms
11.4.5. Others
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
11.5.1. Ingestible
11.5.2. Topical
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
11.6.1. Pain Management
11.6.2. Sleep Support
11.6.3. Skin Health & Beauty
11.6.4. Workout Supplements
11.6.5. Others
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
11.7.1. Hospital Pharmacies
11.7.2. Retail Pharmacies
11.7.3. Online Pharmacies
11.8. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2025
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. GVB Biopharma
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Brains
12.3.3. NOW
12.3.4. Dr. CBD Company Limited
12.3.5. dsm-firmenich
12.3.6. Charlotte's Web, Inc.
12.3.7. Elixinol
12.3.8. Medical Marijuana, Inc.
12.3.9. CV Sciences, Inc.
12.3.10. Irwin Naturals
12.3.11. Diamond CBD
12.3.12. Foria Wellness (Eden Partners LLC)
12.3.13. Medterra CBD
12.3.14. Green Roads
12.3.15. Isodiol International Inc
12.3.16. Garden of Life
12.3.17. Bluebird Botanicals (Gaia Botanicals, LLC)
12.3.18. Endoca
12.3.19. One Farm
12.3.20. Treadwell Farms
12.3.21. CBD Worx
12.3.22. USA Medical
12.3.23. NuLeaf Naturals, LLC
12.3.24. EarlyBird CBD
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations